Analyst Ratings for LB Pharmaceuticals Inc (LBRX)
LBRX Rating Summary
LBRX Price Target Summary
- Highest: $78.00 (Piper Sandler)
- Lowest: $31.00 (Roth/MKM)
- Average: $44.44
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$44.44 (+24%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2026 | BMO Capital | Malcolm Hoffman | New Coverage | Outperform (N/A) |
46.00 (N/A) |
31.41 (35.84) |
14.1% | Details |
| 7/7/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
45.00 (N/A) |
33.41 (35.84) |
7.27% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


